Hypersensitivity myocarditis and COVID-19 vaccines
Kardiol Pol
.
2022;80(1):109-110.
doi: 10.33963/KP.a2021.0166.
Epub 2021 Dec 2.
Authors
Nicholas G Kounis
1
,
Virginia Mplani
2
,
Ioanna Koniari
3
,
Dimitrios Velissaris
4
Affiliations
1
Department of Cardiology, University of Patras Medical School, Patras, Greece. ngkounis@otenet.gr.
2
Intensive Care Unit, University of Patras Medical School, Patras, Greece.
3
Department of Cardiology, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
4
Department of Internal Medicine, University of Patras, Patras, Greece.
PMID:
34856634
DOI:
10.33963/KP.a2021.0166
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Myocarditis*
SARS-CoV-2
Substances
COVID-19 Vaccines